Analysing ADFL's Financials and Valuation to Determine its Investment Prospects The stock of Ador Fontech trades at ₹140 per share – 11 per cent off its all-time high of ₹157.20 per share attained on 5 Jan. 2024. The stock has delivered superior returns over the past five years – 21.16 per cent annually. On a … Continue reading Is Ador Fontech Stock a Buy or Sell?
"Examining the Risks and Rewards of Investing in the Stock of a Niche Manufacturing Company" Firstly, for the benefit of the uninitiated, a brief introduction to the stock: Gandhi Special Tubes principally manufactures a niche product – small-diameter seamless steel tubes that are supplied to the original equipment manufacturers (OEMs) in the automotive, farm equipment, … Continue reading Gandhi Special Tubes: No Tailwinds, No Headwinds Either
Scrutinising Star Cement's Recent Outstanding Performance, Current Valuation, and Investment Prospects The stock of Star Cement gained 10.54 per cent on 22 Mar. 2024 – and closed the day at ₹232 per share – making a new all-time high. The stock now trades at ₹230.60 per share. One-and-a-half years ago, in Sep. 2022, it was … Continue reading Star Cement: Is it Worth Investing Now?
For successful investing… the market price movement should be given the most consideration… often greater than fundamentals and valuation… The phrase ‘market prices reflect everything’ means that, at any moment, a stock’s price reflects all information concerning its business prospect – and every price change then on reflects a change in those prospects. However, this … Continue reading Significance of Interpreting Market Price Action
This post discusses the investment prospects of L G Balakrishnan & Bros., Oriental Carbon & Chemicals, and Associated Alcohols & Breweries. Convergence The Past One-year Performance of L G Balakrishnan & Bros. illustrates the Importance of Margin of Safety in Stock Investing In April 2023, when we previously discussed it, we were bullish on the … Continue reading L G Balakrishnan, Oriental Carbon, Associated Alcohols
LINCOLN PHARMA The stock of Lincoln Pharma is up 90 percent in the last year, a commendable feat considering its low earnings growth, mediocre working capital management, and sluggish capital allocation. However, it is not a poor-quality stock. The stock has good fundamentals, such as a debt-free balance sheet and a high and stable gross … Continue reading Stock Musings – Lincoln Pharma, Dynemic Products, Pakka
This post discusses the financial performance of Meghmani Organics, RACL Geartech, and Kovai Medical Center & Hospital for the quarter ended 31 Dec. 2023 and their investment prospects considering these results. Meghmani Organics Meghmani Organics (MOL) reported its Q3FY24 (quarter ended 31 Dec. 2023) results on Jan. 30, 2024. This quarter's financial performance is a … Continue reading Analysis: Q3FY24 Results – II
An understanding of how manias develop and later devolve into panics helps navigate them with minimal damage. Financial Manias occur when the initial optimism among investors and firms produced by an external event, which promised significant productivity gains and large profit opportunities, escalates into euphoria and widespread speculation. The escalation is propelled by the optimistic … Continue reading The Crossover: When Manias Peak and Distress Follow
This post discusses the financial performance of three stocks – Control Print, SRG Housing, and CSB Bank - for the quarter ended 31 Dec. 2023 and our perspective on the respective stocks’ investment prospects considering these results. Control Print Control Print reported its Q3FY24 results on Jan. 22, 2024. Sales and operating profit were up … Continue reading Analysis: Q3FY24 Results – I
Evaluating the Investment Potential of RACL Geartech RACL Geartech would be one of the best investment decisions I have ever made, but one of my worst investment decisions too. I first purchased the stock at ₹67 per share in September 2018, which I consider one of my best investment decisions. But almost a year later, … Continue reading RACL Geartech’s Dream Run in the Stock Market
AMN CAPITAL 